Anti-SARS-CoV-2 antibody levels predict outcome in COVID-19 patients with type 2 diabetes: a prospective cohort study

Patients with type 2 diabetes (T2D) constitute one of the most vulnerable subgroups in COVID-19. Despite high vaccination rates, a correlate of protection to advise vaccination strategies for novel SARS-CoV-2 variants of concern and lower mortality in this high-risk group is still missing. It is fur...

Descripción completa

Detalles Bibliográficos
Autores principales: Mink, Sylvia, Saely, Christoph H., Leiherer, Andreas, Frick, Matthias, Plattner, Thomas, Drexel, Heinz, Fraunberger, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603091/
https://www.ncbi.nlm.nih.gov/pubmed/37884649
http://dx.doi.org/10.1038/s41598-023-45700-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603091/
https://www.ncbi.nlm.nih.gov/pubmed/37884649
http://dx.doi.org/10.1038/s41598-023-45700-4

Ejemplares similares